VILAF advises a number of multinational pharmaceutical companies, medical equipment companies and a clinical research service company on Vietnamese regulatory and compliance matters especially in relation to product requirements, WTO issues, competition laws, import restrictions, corruption matters and regulatory restrictions on relationships with health care professionals and hospitals.
Some of our notable experience include:
- Advised TE Healthcare and TPG in the acquisition of Vietnam Integrated Medical Service Company Limited from Hanh Phuc International Multi-Specialty Hospital Joint Stock Company and its Hung Viet Hospital Project
- Advised Wellite International Limited in acquiring shares of PYMEPHARCO, a public pharmaceutical company in Vietnam
- Advised STADA in relation to various corporate restructuring and M&A transactions in Vietnam
- Advised a foreign investor in acquiring shares of OPV, a pharmaceutical company in Vietnam
- Advised several global pharmaceutical companies in relation to compliance issues in Vietnam including anti-corruption, relations with doctors, advertising and drug introduction issues
- Advised a leading foreign investor on the formation of a joint venture with a Vietnamese party on the establishment of the first ever high technology health-care park in Vietnam
- Advised a US medical equipment company in relation to compliance issues, drug trading and advertisement, and import of medical equipment
- Advised a global orthopedic products company in relation to the import of medical equipment
- Advised United Pharma (Vietnam) Inc. in relation to various contractual and distribution arrangements in Vietnam
- Advised a Japanese health services company in relation to the acquisition of the entire equity of a Vietnamese medical equipment company
- Advised Research Pharmaceutical Services, Inc., a US clinical research service company on clinical trials regulations and practice in Vietnam